SCHEMBL4781391

SCHEMBL4781391

Nc1cccc2c1CCN(C(=O)OCC1c3ccccc3-c3ccccc31)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 5/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43
KMT2A Q03164 2/20 0.40
UCHL1 P09936 1/20 0.40
FABP7 O15540 2/20 0.40
FABP5 Q01469 2/20 0.40
PRMT5 O14744 3/20 0.39
WDR77 Q9BQA1 3/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
EPHX2 P34913 1/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8276042 0.85 PRMT5 (0.53) ABHD6DPP8DPP9KMT2APRMT5
SCHEMBL4893626 0.81 ABHD6 (0.40) ABHD6DPP8DPP9KMT2AUCHL1
SCHEMBL7533300 0.80 DPP8 (0.52) DPP8DPP9KMT2AFABP7FABP5
SCHEMBL30276669 0.79 TMEM97 (0.58) KMT2AMEN1ALDH1A1GAAMAPT
SCHEMBL4795463 0.79 TMEM97 (0.58) KMT2AMEN1ALDH1A1GAAMAPT
SCHEMBL16523597 0.76 ESR2 (0.48) KMT2APRMT5WDR77EPHX2TMEM97
SCHEMBL13327274 0.76 POLB (0.52) KMT2AFABP7FABP5MEN1ALDH1A1
SCHEMBL22397770 0.76 POLB (0.52) KMT2AFABP7FABP5MEN1ALDH1A1
SCHEMBL29729550 0.76 POLB (0.47) KMT2AFABP7FABP5MEN1ALDH1A1
SCHEMBL1128835 0.76 POLB (0.47) KMT2AFABP7FABP5MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076924-A1 Piperazines as P2X7 antagonists ABBOTT LABORATORIES 2008-03-27 US disclosed
WO-2008005368-A2 PIPERAZINES AS P2X7 ANTAGONISTS ABBOTT LABORATORIES (US) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076924-A1 Piperazines as P2X7 antagonists P2RX7, P2RX1, P2RX2 ABHD6 4438/4885DPP8 1454/4885DPP9 1689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.